Auswirkungen der Bestrahlung mit UVB, UVA-1 und PUVA-1 auf das Funktionsverhalten humaner dermaler Mastzellen nach Stimulation mit anti-IgE und Substanz PMarc StrathmannI111.11.221.31.4345623#6981.561.5.1781.5.21.5.391.6101.7111.812132143153.11617183.1.1193.1.22021623#8453.2223.2.1233.2.224605#1613.2.33.2.43.2.525263.2.63.2.727627#24428605#303.2.8293.2.9303.3314324.133594#30834594#300594#30035615#3374.23637594#2844.33839594#31840594#324594#3144.44142483#387483#38743483#387483#388483#40344476#387481#38745483#385481#387481#3854.546475484950515253545556575865960 Abkürzungsverzeichnis61 Literaturverzeichnis626364656667686970 Erklärung an Eides Statt71 Danksagung72 Lebenslauf73deInhaltsverzeichnisHilfe Literaturverzeichnis 1. Bienenstock J, Tomioka M, et al.: The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int Arch Allergy Appl Immunol 1987: 82 (3-4): 238-43. 2. Bienenstock J, MacQueen G, et al.: Mast cell/nerve interactions in vitro and in vivo. Am Rev Respir Dis 1991: 143 (3 Pt 2): S55-8. 3. Kirshenbaum AS, Kessler SW, et al.: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991: 146 (5): 1410-5. 4. Henz BM, Maurer M, et al.: Mast cells as initiators of immunity and host defense. Exp Dermatol 2001: 10 (1): 1-10. 5. Metcalfe DD, Baram D, et al.: Mast cells. Physiol Rev 1997: 77 (4): 1033-79. 6. Weber S, Kruger-Krasagakes S, et al.: Mast cells. Int J Dermatol 1995: 34 (1): 1-10. 7. Schulman ES, Kagey-Sobotka A, et al.: Heterogeneity of human mast cells. J Immunol 1983: 131 (4): 1936-41. 8. Irani AM, Craig SS, et al.: Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 1987: 138 (12): 4381-6. 9. Blank U, Ra C, et al.: Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 1989: 337 (6203): 187-9. 10. Lin S, Cicala C, et al.: The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma-mediated cell activation signals. Cell 1996: 85 (7): 985-95. 11. Ra C, Jouvin MH, et al.: Complete structure of the mouse mast cell receptor for IgE (Fc epsilon RI) and surface expression of chimeric receptors (rat-mouse-human) on transfected cells. J Biol Chem 1989: 264 (26): 15323-7. 12. Kihara H, Siraganian RP: Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J Biol Chem 1994: 269 (35): 22427-32. 13. Shiue L, Zoller MJ, et al.: Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE. J Biol Chem 1995: 270 (18): 10498-502. 14. Kinet JP, Jouvin MH, et al.: IgE receptor (Fc epsilon RI) and signal transduction. Eur Respir J Suppl 1996: 22 : 116s-118s. 15. Paolini R, Jouvin MH, et al.: Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement. Nature 1991: 353 (6347): 855-8. 16. Paolini R, Renard V, et al.: Different roles for the Fc epsilon RI gamma chain as a function of the receptor context. J Exp Med 1995: 181 (1): 247-55. 17. Jouvin MH, Adamczewski M, et al.: Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J Biol Chem 1994: 269 (8): 5918-25. 18. Streb H, Irvine RF, et al.: Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature 1983: 306 (5938): 67-9. 19. Hoth M: Depletion of intracellular calcium stores activates an outward potassium current in mast and RBL-1 cells that is correlated with CRAC channel activation. FEBS Lett 1996: 390 (3): 285-8. 20. Wesselborg S, Fruman DA, et al.: Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). J Biol Chem 1996: 271 (3): 1274-7. 21. Smorodchenko A, Lippert U, et al.: Expression and translocation of lysosome-associated membrane proteins (LAMPs) in anti IgE-activated human mast cells. Arch Derm Res 2001 abstr.: 293 : 45. 22. Kannan K, Stewart RM, et al.: Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. Cell Immunol 1996: 171 (1): 10-9. 23. Chang MH, Karageorgos LE, et al.: CD107a (LAMP-1) and CD107b (LAMP-2). J Biol Regul Homeost Agents 2002: 16 (2): 147-51. 24. Bell CR, Horowitz ED, et al.: Profound inhibition of GPIb, GPIIb/IIIa, PECAM-1, CD63, and CD107 in a chronic drug addict: selecting controls for platelet flow cytometry in the inner city hospital. Thromb Res 2001: 101 (3): 217-8. 25. White DM: Release of substance P from peripheral sensory nerve terminals. J Peripher Nerv Syst 1997: 2 (3): 191-201. 26. Suzuki R, Furuno T, et al.: Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999: 163 (5): 2410-5. 27. Schenker C, Mroz EA, et al.: Release of substance P from isolated nerve endings. Nature 1976: 264 (5588): 790-2. 28. Pang X, Boucher W, et al.: Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Urology 1996: 47 (3): 436-8. 29. Nicoll RA, Schenker C, et al.: Substance P as a transmitter candidate. Annu Rev Neurosci 1980: 3 : 227-68. 30. Pawlak M, Schmidt RF, et al.: The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat. Eur J Pain 2001: 5 (1): 69-79. 31. Piotrowski W, Devoy MA, et al.: The substance P receptor on rat mast cells and in human skin. Agents Actions 1984: 14 (3-4): 420-4. 32. Piotrowski W, Foreman JC: On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn Schmiedebergs Arch Pharmacol 1985: 331 (4): 364-8. 33. de Vries A, Dessing MC, et al.: Nerve growth factor induces a neurokinin-1 receptor- mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999: 159 (5 Pt 1): 1541-4. 34. Cocchiara R, Bongiovanni A, et al.: Inhibitory effect of neuraminidase on SP-induced histamine release and TNF-alpha mRNA in rat mast cells: evidence of a receptor-independent mechanism. J Neuroimmunol 1997: 75 (1-2): 9-18. 35. Lieb K, Schaller H, et al.: Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6. J Neurochem 1998: 70 (4): 1577-83. 36. Krumins SA, Broomfield CA: C-terminal substance P fragments elicit histamine release from a murine mast cell line. Neuropeptides 1993: 24 (1): 5-10. 37. Baumruker T, Prieschl E: Mast Cells and their Activation - from the Molecular Mechanisms to Clinical Relevance. Mod Asp Immunobiol 2001: 1 (6): 256-262. 38. Moqbel R, Lacy P: Exocytotic events in eosinophils and mast cells. Clin Exp Allergy 1999: 29 (8): 1017-22. 39. Buckley IK, Ryan GB: Increased vascular permeability. The effect of histamine and serotonin on rat mesenteric blood vessels in vivo. Am J Pathol 1969: 55 (3): 329-47. 40. Schwartz L, Irani A, et al.: Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells. J Immunolog 1987: 138 (8): 2611-2615. 41. Schwartz B: Structure and function of human mast cell tryptase. Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function - Raven Press, Ltd.,

NY

1995: . 42. Abe M, Kurosawa M, et al.: Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin Exp Allergy 1998: 28 (12): 1509-17. 43. Akimoto S, Ishikawa O, et al.: Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol 1998: 138 (3): 399-406. 44. Aldenborg F, Enerback L: The immunohistochemical demonstration of chymase and tryptase in human intestinal mast cells. Histochem J 1994: 26 (7): 587-96. 45. Harvima IT, Naukkarinen A, et al.: Mast cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 1993: 285 (4): 184-92. 46. Jarvikallio A, Naukkarinen A, et al.: Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 1997: 136 (6): 871-7. 47. Ruddle N: Tumor nekrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr Opin Immunol 1992: 4 (3): 327-32. 48. Brazis P, De Mora F, et al.: IgE enhances Fc epsilon RI expression and IgE-dependent TNF-alpha release from canine skin mast cells. Vet Immunol Immunopathol 2002: 85 (3-4): 205-12. 49. Cocchiara R, Bongiovanni A, et al.: Substance P selectively activates TNF-alpha mRNA in rat uterine immune cells: a neuroimmune link. Neuroreport 1997: 8 (13): 2961-4. 50. Coward WR, Okayama Y, et al.: NF-kappaB and TNF-alpha: A Positive Autocrine Loop in Human Lung Mast Cells? J Immunol 2002: 169 (9): 5287-93. 51. Gibbs BF, Wierecky J, et al.: Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 2001: 10 (5): 312-20. 52. Gomez-Guerrero C, Lopez-Armada MJ, et al.: Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 1994: 153 (11): 5247-55. 53. Sirota L, Punsky I, et al.: Effect of indomethacin on IL-1beta, IL-6 and TNFalpha production by mononuclear cells of preterm newborns and adults. Acta Paediatr 2000: 89 (3): 331-5. 54. Pujol-Borrell R, Todd I, et al.: HLA class II induction in human islet cells by interferon-gamma plus tumor necrosis factor or lymphotoxin. Nature 1987: 326 (6110): 304-6. 55. Oliff A: The role of tumor necrosis factor (cachectin) in cachexia. Cell 1988: 54 (2): 141-2. 56. Tracey K, Fong Y, et al.: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987: 330 (6149): 662-4. 57. Hack C, Aarden L, et al.: Role of cytokines in sepsis. Adv Immunol 1997: 66 : 101-95. 58. Weiss JW, Drazen JM, et al.: Comparative bronchoconstrictor effects of histamine, leukotriene C, and leukotriene D in normal human volunteers. Trans Assoc Am Physicians 1982: 95 : 30-5. 59. Czarnetzki BM, Grabbe J, et al.: Mast cells in the cytokine network: the what, where from and what for. Exp Dermatol 1995: 4 (4 Pt 2): 221-6. 60. Jehle AB, Li Y, et al.: Endotoxin and mast cell granule proteases synergistically activate human coronary artery endothelial cells to generate interleukin-6 and interleukin-8. J Interferon Cytokine Res 2000: 20 (4): 361-8. 61. Kruger-Krasagakes S, Moller A, et al.: Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996: 106 (1): 75-9. 62. Moller A, Lippert U, et al.: Human mast cells produce IL-8. J Immunol 1993: 151 (6): 3261-6. 63. Grabbe J, Haas N, et al.: [The mast cell]. Hautarzt 1994: 45 (1): 55-63; quiz 64. 64. Krutmann J: Ultraviolet A-1 irradiation as a tool to study the pathogenesis of atopic dermatitis. Methods Enzymol 2000: 319 : 296-302. 65. Krutmann J: Phototherapy for atopic dermatitis. Clin Exp Dermatol 2000: 25 (7): 552-8. 66. Krutmann J, Schopf E: High-dose-UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992: 176 : 120-2. 67. Grabbe J, Welker P, et al.: High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996: 107 (3): 419-22. 68. Morita A, Kobayashi K, et al.: Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000: 43 (4): 670-4. 69. Bruls W, Slaper H, et al.: Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visibe wavelengths. Photochem Photobiol 1984: 40 (4): 485-94. 70. Kripke ML, Cox PA, et al.: Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci U S A 1992: 89 (16): 7516-20. 71. Yarosh DB: The role of DNA damage and UV-induced cytokines in skin cancer. J Photochem Photobiol B 1992: 16 (1): 91-4. 72. Gilchrest BA, Zhai S, et al.: Treatment of human melanocytes and S91 melanoma cells with the DNA repair enzyme T4 endonuclease V enhances melanogenesis after ultraviolet irradiation. J Invest Dermatol 1993: 101 (5): 666-72. 73. Ceccoli J, Rosales N, et al.: Encapsulation of the UV-DNA repair enzyme T4 endonuclease V in liposomes and delivery to human cells. J Invest Dermatol 1989: 93 (2): 190-4. 74. Kibitel JT, Yee V, et al.: Enhancement of ultraviolet-DNA repair in denV gene transfectants and T4 endonuclease V-liposome recipients. Photochem Photobiol 1991: 54 (5): 753-60. 75. Oh HK, Teo AK, et al.: Conformational change in human DNA repair enzyme O6-methylguanine-DNA methyltransferase upon alkylation of its active site by SN1 (indirect-acting) and SN2 (direct-acting) alkylating agents: breaking a "salt-link". Biochemistry 1996: 35 (38): 12259-66. 76. Wolf P, Yarosh DB, et al.: Effects of sunscreens and a DNA excision repair enzyme on ultraviolet radiation-induced inflammation, immune suppression, and cyclobutane pyrimidine dimer formation in mice. J Invest Dermatol 1993: 101 (4): 523-7. 77. McGregor W: DNA repair, DNA replication, and UV mutagenesis. J investig Dermatol Symp Proc 1999: 4 (1): 1-5. 78. Tada-Oikawa S, Oikawa S, et al.: Role of ultraviolet A-induced oxidative DNA damage in apoptosis via loss of mitochondrial membrane potential and caspase-3 activation. Biochem Biophys Res Commun 1998: 247 (3): 693-6. 79. Sies H: Oxidative stress: from basic research to clinical application. Am J Med 1991: 91 (3C): 31S-38S. 80. Pacifici R, Davies K: Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 1991: 37 (1-3): 166-80. 81. Pourzand C, Watkin R, et al.: Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: the role of ferritin. Proc Natl Acad Sci USA 1999: 96 (12): 6751-6. 82. Vile G, Tyrell R: UVA radiation-induced oxidative damage to lipids and proteins in vitro and in human skin fibroblasts is dependent on iron and singlet oxygen. Free Radic Biol Med 1995: 18 (4): 721-30. 83. Morliere P, Moysan A, et al.: UVA-induced lipid peroxidation in cultured human fibroblasts. Biochim Biophys Acta 1991: 1084 (3): 261-8. 84. Punnonen K, Jansen C, et al.: Effects of in vitro UVA irradiation and PUVA treatment on membrane fatty acids and activities of antioxidants enzymes in human keratinocytes. J Invest Dermatol 1991: 96 (2): 255-9. 85. Cadet J, Voituriez L, et al.: A new class of psoralen photoadducts to DNA components: isolation and characterization of 8-MOP adducts to the osidic moiety of 2'-deoxyadenosine. J Photochem Photobiol B 1988: 2 (3): 321-39. 86. Johnston BH, Johnson MA, et al.: Psoralen-DNA photoreaction: controlled production of mono- and diadducts with nanosecond ultraviolet laser pulses. Science 1977: 197 (4306): 906-8. 87. Pathak MA, Kramer DM: Photosensitization of skin in vivo by furocoumarins (psoralens). Biochim Biophys Acta 1969: 195 (1): 197-206. 88. Liu Z, Lu Y, et al.: PUVA (8-methoxy-psoralen plus ultraviolet A) induces the formation of 8-hydroxy-2'-deoxyguanosine and DNA fragmentation in calf thymus DNA and human epidermoid carcinoma cells. Free Radic Biol Med 1999: 27 (1-2): 127-33. 89. Rae V, Yoshikawa T, et al.: An ultraviolet B radiation protocol for complete depletion of human epidermal Langerhans cells. J Dermatol Surg Oncol 1989: 15 (11): 1199-202. 90. Siraganian RP: Refinements in the automated fluorometric histamine analysis system. J Immunol Methods 1975: 7 (2-3): 283-90. 91. Fritsch P, Vanscheidt W: Flowzytometrie in der Dermatologie. Hautarzt 1996: 47 : 561-578. 92. Nishigori C, Yarosh DB, et al.: Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc Natl Acad Sci U S A 1996: 93 (19): 10354-9. 93. de Vos S, Brach M, et al.: Post-transcriptional regulation of interleukin-6 gene expression in human keratinocytes by ultraviolet B radiation. J Invest Dermatol 1994: 103 (1): 92-6. 94. Petit-Frere C, Clingen PH, et al.: Induction of interleukin-6 production by ultraviolet radiation in normal human epidermal keratinocytes and in a human keratinocyte cell line is mediated by DNA damage. J Invest Dermatol 1998: 111 (3): 354-9. 95. Bernerd F, Asselineau D: UVA exposure of human skin reconstructed in vitro induces apoptosis of dermal fibroblasts: subsequent connective tissue repair and implications in photoaging. Cell Death Differ 1998: 5 (9): 792-802. 96. Guhl S, Hartmann K: Ultraviolet irradiation induces apoptosis in human immature, but not in skin mast cells. in press 2003: . 97. Benyon R, Robinson C, et al.: Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol 1989: 97 (3): 898-904. 98. Church M, Okayama Y, et al.: Mediator secretion from human skin mast cells provocated by immunological and non-immunological stimulation. Skin Pharmakol 1991: 4 Suppl 1 : 15-24. 99. Cocchiara R, Albeggiani G, et al.: Histamine and Tumor Necrosis Factor production from purified rat brain mast cells mediated by substance P. NeuroReport 1999: 10 (3): 575-578. 100. Janiszewski J, Bienenstock J, et al.: Picomolar doses of substance P trigger electrical responses in mast cells without degranulation. Am J Physiol 1994: 267 (1 Pt 1): C138-45. 101. Okada T, Hirayama Y, et al.: Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells. Inflamm Res 1999: 48 (5): 274-279. 102. Andoh T, Nagasawa T, et al.: Substance P Induction of Itch-Associated Response Mediated by Cutaneus NK1 Tachykinin Receptors in Mice. J Pharmacol Exp Ther 1998: 286 (3): 1140-1145. 103. Brooks A, CJ. W: Reactive oxygen species generation by mast cells in response to substance P: A NK1-receptor-mediated event. Inflamm Res 1999: Suppl 2 : S121. 104. Holst B, Hastrup H, et al.: Two active molecular phenotypes of the tachykinine NK1 receptor revealed by G-protein fusions and mutagenesis. J Biol Chem 2001: 276 (23): 19793-19799. 105. Fiebich BL, Schleicher S, et al.: The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J Immunol 2000: 165 (10): 5606-11. 106. Furutani K, Koro O, et al.: Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro. Arch Dermatol Res 1999: 291 (7-8): 166-473. 107. Klinker J, Hagelüken A, et al.: Direct and indirect receptor-independent G-protein activation by cationic-amphiphilic substances: Studies with mast cells, HL-60 human leukemic cells and purified G-proteins. Exp Dermatol 1995: 4 (4 Pt 2): 231-239. 108. Repke H, Bienert M: Mast-cell activation - a receptor-independent mode of substance P action? FEBS Lett 1987: 221 (2): 236-240. 109. Vink AA, Shreedhar V, et al.: Cellular target of UVB-induced DNA damage resulting in local suppression of contact hypersensitivity. J Photochem Photobiol B 1998: 44 (2): 107-11. 110. Krutmann J, Morita A: Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Investig Dermatol Symp Proc 1999: 4 (1): 70-2. 111. Vink AA, Henegouwen B, et al.: Removal of UV-induced DNA lesions in mouse epidermis soon after irradiation. J Photochem Photobiol B 1994: 24 (1): 25-31. 112. Vink AA, Moodycliffe AM, et al.: The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc Natl Acad Sci U S A 1997: 94 (10): 5255-60. 113. Park YM, Kim CW: The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes. J Dermatol Sci 1999 : 22 (1) : 17-23. 114. Okayama Y, Ono Y, et al. : Human skin mast cells produce TNF-alpha by Substance P. Int Arch Allergy Immunol 1998: 117 (Suppl 1): 48-51. 115. Guhl S, Stefaniak R, et al.: Bivalent and immunomodulating impact of UV-light on human skin mast cells - low level mediator release at baseline but potent suppression upon mast cell triggering. in press 2003: . 116. Winchester B: Lysosomal membrane proteins. Eur J Paediatr Neur Review 2001: suppl A : 11-9. 117. Blott E, Griffiths G: Secretory lysosomes. Nat Rev Mol Cell Biol 2002: 3 : 122-31. 118. Monneret G, Benoit Y, et al.: Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin Immunol 2002: 102 : 192-9.